Au8® treatment was demonstrated to improve survival in ALS patients by up to 14.8 months. <li /> The findings come ...

Famed physicist Stephen Hawking took gravity to its ultimate limits. In doing so, he made a number of significant ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Cognixion is recruiting adults with ALS for a clinical trial testing BCI headset ONE Axon-R as a communication aid.

The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical ...

Lorem, a nonprofit foundation, today announced that nine patients with an ultra-rare type of amyotrophic lateral sclerosis (ALS) have been treated during the first year of a multi-year grant from the ...

ALS Canada has named 39 Canadians to receive the King Charles III Coronation Medal for their efforts into research and advocacy for ALS.

Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.

Scientists at St. John’s University, The University of Pennsylvania and Université de Montréal have identified poly(ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors reported to be useful for the ...

Cognixion's Axon-R headset is a device designed to read brain activity using EEG as a direct input for controls. Using brain ...

Researchers have revealed that vascular dysfunction can contribute to neurodegenerative diseases including Alzheimer's and ...

Researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis ...